Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis

Acta Neurologica Scandinavica

Volumn 94, Issue 4, 1996, Pages 287-293

  Kitze, B ^a,c   Usuku, K ^a   Yashiki, S ^a   Ijichi, S ^a   Fujiyoshi, T ^a   Nakamura, M ^b   Izumo, S ^a   Osame, M ^a   Sonoda, S ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

B cell epitopes; HTLV1 associated myelopathy tropical spastic paraparesis (HAM TSP); Human leukocyte antigens (HLA); Human T cell lymphotropic virus type 1 (HTLV 1); Intrathecal immune response

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY TEST; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOGENETICS; SPASTIC PARAPLEGIA; SPINAL CORD INFECTION;

EID: 0029804657     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb07067.x     Document Type: Article

References (23)

1. UCHIYAMA T, YODOI J, SAGAWA K, TAKATSUKI K, UCHINO H. Adult T-cell leukemia: Clinical and hematological features of 16 cases. Blood 1977: 50: 481-492.
2. OSAME M, USUKU K, IZUMO S, et al. HTLV-I associated myelopathy. A new clinical entity. Lancet 1986: 1: 1031-1032.
3. GESSAIN A, BARIN F, VERNANT JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985: 2: 407-410.
4. USUKU K, SONODA S, OSAME M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988: 23(suppl): S143-S150.
5. USUKU K, NISHIZAWA M, MATSUKI K, et al. Association of a particular amino acid sequence of the HLA DRB1 chain with HTLV-I-associated myelopathy. Eur J Immunol 1990: 20: 1603-1606.
6. SONODA S, YASHIKI S, FUJIYOSHI T, et al. Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy. Gann Monograph on Cancer Research 1992: 39: 81-93.
7. IWASAKI Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990: 96: 103-123.
8. UMEHARA F, IZUMO S, NAKAGAWA M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropath Exp Neurol 1993: 52: 424-430.
9. LINK H, CRUZ M, GESSAIN A, GOUT O, DE THE G, KAM HANSEN S. Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG anti-bodies in cerebrospinal fluid and serum. Neurology 1989: 39: 1566-1572.
10. KITZE B, PUCCIONI-SOHLER M, SCHÄFFNER J, et al. Specificity of intrathecal IgG synthesis for HTLV-I core and envelope proteins in HTLV-I associated myelopathy. Acta Neurol Scand 1995: 92: 213-217.
11. KITZE B, USUKU K, IZUMO S, et al. Diversity of the intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J Neurol 1996: 243: 393-400.
12. PALKER TJ, TANNER ME, SCEARCE RM, STREILEIN RD, CLARK ME, HAYNES BF. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol 1989: 142: 971-978.
13. CHEN YA, LEE T, SAMUEL KP, et al. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people. J Virol 1989: 63: 4952-4957.
14. IDA H, KURATA A, EGUCHI K, et al. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals. J Clin Immunol 1991: 11: 143-151.
15. NAKAMURA M, KUROKI M, KIRA J, et al. Elevated antibodies to synthetic peptides of HTLV-I envelope transmembrane glycoproteins in patients with HAM/TSP. J Neuroimmunol 1991: 35: 167-177.
16. INOUE Y, KURODA N, SHIRAKI H, SATO H, MAEDA Y. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I. Int J Cancer 1992: 52: 877-880.
17. DESGRANGES C, SOUCHE S, VERNANT JC, SMADJA D, VAHLNE A, HORAL P. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res Hum Retroviruses 1994: 10: 163-173.
18. OSAME M. Review of WHO Kagoshima Meeting and Diagnostic Guidelines for HAM/TSP. In: Blattner WA, ed. Human Retrovirology: HTLV. New York: Raven Press, 1990: 191-197.
19. BODMER JG, MARSH SGE, ALBERT ED, et al. Nomenclature for factors of the HLA system. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991 - Proceedings of the eleventh international Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 17-31.
20. REIBER H, FELGENHAUER K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987: 163: 319-328.
21. REIBER H, LANGE P. Quantification of virus-specific anti-bodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991: 37: 1153-1160.
22. NISHIMURA Y, OKUBO R, MINATO S, et al. A possible association between HLA and HTLV-1-associated myelopathy (HAM) in Japanese. Tissue Antigens 1991: 37: 230-231.
23. NAKAGAWA M, IZUMO S, IJICHI S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. JNV 1995: 1: 50-61.